Treatment of severe refractory pruritus with fractionated plasma separation and adsorption (Prometheus®)
- 1 January 2006
- journal article
- research article
- Published by Taylor & Francis Ltd in Scandinavian Journal of Gastroenterology
- Vol. 41 (10), 1212-1217
- https://doi.org/10.1080/00365520600610154
Abstract
Objective. Severe pruritus is a serious complication of cholestatic liver disease. Prometheus® is a recently introduced extracorporeal liver support system with direct toxin adsorption of the patient's albumin fraction (FPSA; fractionated plasma separation and adsorption). Here we report on the effect of Prometheus therapy in patients with intractable cholestatic pruritus. Material and methods. Seven patients with different liver diseases and severe pruritus refractory to all medical treatment efforts for more than 4 weeks were treated with Prometheus (3–5 times, 18±3 h total). Pruritus intensity was assessed using the visual analogue scale (VAS; from 0 = no pruritus to 10 = unbearable pruritus), and VAS, serum bile acids and total bilirubin were evaluated directly before and after Prometheus treatment, as well as 4 weeks later. Results. After Prometheus therapy, VAS values had dropped significantly from 9±1 to 3±3 (ppConclusions. Prometheus therapy significantly improved refractory pruritus in all patients with elevated bile acid levels, but in some patients the clinical benefit was of short duration. The clinical findings suggest that we have to better characterize those patients who might derive a long-lasting benefit from this invasive and expensive treatment.Keywords
This publication has 20 references indexed in Scilit:
- Emerging Indications for Albumin DialysisThe American Journal of Gastroenterology, 2005
- The Pathology of CholestasisSeminars in Liver Disease, 2004
- Treatment of refractory cholestatic pruritus after liver transplantation with albumin dialysisLiver Transplantation, 2004
- Effect of molecular adsorbent recirculating system in hepatitis C virus-related intractable pruritusLiver Transplantation, 2003
- Pathophysiologie und Therapie von Pruritus bei cholestatischen LeberkrankheitenZeitschrift für Gastroenterologie, 2003
- Pruritus in cholestatic and other liver diseasesAlimentary Pharmacology & Therapeutics, 2003
- Extracorporal albumin dialysis (MARS) improves cholestasis and normalizes low apo A‐I levels in a patient with benign recurrent intrahepatic cholestasis (BRIC)Liver International, 2002
- The Molecular Adsorbents Recycling System as a Liver Support System Based on Albumin Dialysis: A Summary of Preclinical Investigations, Prospective, Randomized, Controlled Clinical Trial, and Clinical Experience from 19 CentersArtificial Organs, 2002
- Cholestatic Liver Diseases and Health-Related Quality of LifeThe American Journal of Gastroenterology, 2000
- A New Procedure for the Removal of Protein Bound Drugs and ToxinsASAIO Journal, 1993